Brief: ImmuCell Makes Important Regulatory Submission
22/02/2021 22:36
Feb 22 (Reuters) - ImmuCell Corp ICCC.O :
* IMMUCELL MAKES IMPORTANT REGULATORY SUBMISSION AND
ANNOUNCES
UNAUDITED FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2020
* IMMUCELL CORP - QTRLY DILUTED NET INCOME PER SHARE $0.03
Source text for Eikon: ID:nGNX2HThR2
Further company coverage: ICCC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year